Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,174Revenue (TTM) $M1,599Net Margin (%)44.6Altman Z-Score11.9
Enterprise Value $M5,123EPS (TTM) $15.2Operating Margin %66.4Piotroski F-Score6
P/E(ttm)8.1Beneish M-Score-2.1Pre-tax Margin (%)66.3Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %--Quick Ratio4.0Cash flow > EarningsN
Price/Sales3.65-y EBITDA Growth Rate %33.5Current Ratio4.3Lower Leverage y-yY
Price/Free Cash Flow9.6y-y EBITDA Growth Rate %10.8ROA % (ttm)31.9Higher Current Ratio y-yY
Dividend Yield %--PEG0.2ROE % (ttm)40.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M45.0ROIC % (ttm)92.9Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

UTHR is held by these investors:



UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE AChairman & CEO 2017-04-20Sell1,260$121.141.3view
ROTHBLATT MARTINE AChairman & CEO 2017-04-13Sell1,258$122.120.48view
ROTHBLATT MARTINE AChairman & CEO 2017-04-06Sell1,257$122.390.26view
ROTHBLATT MARTINE AChairman & CEO 2017-03-30Sell1,230$134.56-8.81view
ROTHBLATT MARTINE AChairman & CEO 2017-03-23Sell1,219$139.33-11.93view
Thompson Tommy GDirector 2017-03-22Sell2,000$139.37-11.95view
ROTHBLATT MARTINE AChairman & CEO 2017-03-16Sell1,218$140.16-12.45view
ROTHBLATT MARTINE AChairman & CEO 2017-03-09Sell1,206$146.72-16.36view
ROTHBLATT MARTINE AChairman & CEO 2017-03-02Sell1,203$148.49-17.36view
ROTHBLATT MARTINE AChairman & CEO 2017-02-23Sell1,208$145.16-15.47view

Quarterly/Annual Reports about UTHR:

News about UTHR:

Articles On GuruFocus.com
United Therapeutics Corporation To Report First Quarter 2017 Financial Results Before The Market Ope Apr 19 2017 
United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump Apr 03 2017 
United Therapeutics Announces Decision From Patent Trial And Appeal Board And Issuance Of New Patent Mar 31 2017 
Gurus Invest in Undervalued Biotech Stocks Nov 25 2016 
6 Undervalued Stocks Trading Below the Peter Lynch Value Oct 26 2016 
These Five Stocks Show a Combination of Value and Growth Aug 03 2016 
Worst Performance YTD: MasterCard, Lazard Aug 03 2016 
5 Mid-Cap Stocks With Low Enterprise Multiples Aug 03 2016 
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? Jul 01 2016 
Gurus Invest in Top Biotechnology Stocks Jun 20 2016 

More From Other Websites
Rising Revenue and Earnings: Mistubishi Financial, United Therapeutics Apr 19 2017
United Therapeutics Corporation To Report First Quarter 2017 Financial Results Before The Market... Apr 19 2017
PolarityTE(TM), Inc. Recruits Key Additions to Management Apr 18 2017
5 Major Drug Stocks Likely to Beat Q1 Earnings Estimates Apr 17 2017
Company News for April 04, 2017 Apr 04 2017
United Therapeutics Tanks, Remodulin Pump Launch Delayed Apr 04 2017
Why DryShips, United Therapeutics, and Fiat Chrysler Automobiles Slumped Today Apr 03 2017
SteadyMed Wins Patent Challenge Vs United Therapeutics Apr 03 2017
United Therapeutics shares fall after regulatory delays push back product launch Apr 03 2017
United Therapeutics loses challenge to its drug patent Apr 03 2017
Stocks Open Higher; United Therapeutics Dives Apr 03 2017
Biotech Movers: Novocure, United Therapeutics, Kite Pharma Apr 03 2017
Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review Apr 03 2017
United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump Apr 03 2017
United Therapeutics Announces Decision From Patent Trial And Appeal Board And Issuance Of New... Mar 31 2017
Why Is United Therapeutics (UTHR) Down 5.6% Since the Last Earnings Report? Mar 28 2017
Is United Therapeutics a Great Stock for Value Investors? Mar 21 2017
How These Drug Makers Stocks are Faring? -- Orexigen Therapeutics, United Therapeutics, DURECT, and... Mar 20 2017
3 Drug Stocks With Some of the Highest Profit Margins Mar 17 2017
United Therapeutics Stock Slumping on Credit Suisse Rating Mar 16 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)